"Hashtag Biotech" is a new weekly column in which OneMedPlace explores the power of Twitter and other social media tools in facilitating emerging growth company development. This week, we identify the most intriguing biotech investors using Twitter.
Urology and women's health have been areas of substantial M&A activity during the last 10 years as the major medtech consolidators have been busy building separate business units to address these medical needs.
In the halls of government agencies throughout Washington, DC, plans are being made to implement reform measures that will reshape the nation’s healthcare policies—and the health of millions of Americans.
Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. The Diagnostics and Personalized Medicine panel explores the changing world of diagnostics, bringing together executives, experienced venture capi
Over 500,000 people will die from cancer in the United States this year. There are many companies developing diagnostics for early detection and advanced therapies to address the various types of cancer.
Advances in structural heart repair/replacement, cardiac rhythm management, interventional techniques, cell replacement and regeneration therapies continue to refine one of the most successful areas of modern medicine: cardiac care.
Combing the newest information technology and healthcare ideas to create products that help reduce costs and allows more patient control is one reason why Health Tech is one of the fastest growing sectors in the life science, and healthcare industry.